Predictors of clinical response after rTMS treatment of patients suffering from drug-resistant depression
Abstract Repeated transcranial magnetic stimulation (rTMS) is a therapeutic brain-stimulation technique that is particularly used for drug-resistant depressive disorders. European recommendations mention the effectiveness of 30 to 64%. The failure rate of treatment is high and clinical improvement i...
Guardado en:
Autores principales: | Aurélie Lacroix, Benjamin Calvet, Benjamin Laplace, Marilyne Lannaud, Brigitte Plansont, Sandrine Guignandon, Patrice Balestrat, Murielle Girard |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f7e70073fb2a40c297341aa2389b336a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression
por: Chen SJ, et al.
Publicado: (2013) -
Repetitive transcranial magnetic stimulation (rTMS) in the treatment of bipolar depression
por: Tomáš Novák, et al.
Publicado: (2021) -
Electrophysiological and behavioral effects of bilateral and unilateral rTMS on rumination and depression
por: Reza Kazemi, et al.
Publicado: (2021) -
Is there an optimal rTMS target to treat chronic tinnitus?
por: Nathan Watson, et al.
Publicado: (2021) -
How to use multimodal neuroimaging to personalize rTMS parameters for depression treatment
por: Debby Klooster, et al.
Publicado: (2021)